What is an oncology drug supply chain marketplace in India?

A B2B digital platform that aggregates demand from cancer centres and tertiary hospitals, connects them with verified pharmaceutical wholesalers and generic manufacturers, and automates procurement to solve drug stockouts and reduce costs. The Indian oncology market is ₹8,000–12,000 crore annually, with significant supply fragmentation causing hospital shortages and patient hardship.

How much does it cost to start this marketplace in India?

Estimated ₹45–70 lakh for MVP: tech platform (₹20–25 lakh), regulatory approvals (₹8–10 lakh), pilot working capital (₹15–20 lakh), and operations (₹10 lakh). Scale to profitability within 18–24 months with 50+ hospital partners and ₹500 crore GMV.

Is this opportunity profitable in India?

Yes. At ₹500 crore annual GMV (realistic within 3 years across 100+ hospitals), an 8–12% platform commission generates ₹40–60 crore revenue. With SaaS subscriptions (₹5–10 lakh per hospital) and analytics licensing, net margins of 35–45% are achievable by year 3, targeting ₹15–20 crore EBITDA.

What regulations apply to this marketplace in India?

Pharma Distribution License (Schedule M, Drugs and Cosmetics Rules 1945); GST registration (5% on B2B services); compliance with Essential Commodities Act for price monitoring on oncology drugs; hospital procurement standards (GeM guidelines where mandated); and adherence to NPPA (National Pharmaceutical Pricing Authority) price caps for essential medicines.

Oncology Drug Supply Marketplace India — Hospital Aggregation

AI SummaryThe oncology drug supply chain marketplace addresses a ₹1,200–1,800 crore addressable segment within India's ₹8,000–12,000 crore annual oncology market. Cancer centres and tertiary hospitals face chronic drug stockouts, forcing patients to source from expensive private channels—a friction point revealed in 2026 news reports from Coimbatore. A B2B marketplace aggregating hospital demand and connecting verified wholesalers can reduce procurement friction by 60%, lower patient costs by 15–20%, and capture 8–12% platform fees on transactions. MBA graduates with healthcare supply chain experience, former hospital procurement officers, and healthcare entrepreneurs are best positioned to launch this venture.